Silva RC, Domingues HS, Salgado AJ, Teixeira FG (2022) From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson’s disease? Neural Regen Res 17:933–936
Article CAS PubMed Google Scholar
Beitz JM (2014) Parkinson’s disease: a review. Front Biosci (Schol Ed) 6:65–74
Zhu X, Gan J, Wu N, Zhang Y, Liu Z (2024) The simultaneous presence of demoralization, apathy, and depression has a detrimental impact on both cognitive function and motor symptoms in Parkinson’s disease patients. Front Psychiatry 15:1345280
Article PubMed PubMed Central Google Scholar
Aarsland D, Halliday BL, Geurtsen GM, Ballard GJ C., Ray Chaudhuri K.,Weintraub D. (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:47
Costello H, Reeves BAJ, Weil S, Joyce RS, Howard EM, Roiser R J. P (2022) Disrupted reward processing in Parkinson’s disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 93:555–562
Elsworth JD (2020) Parkinson’s disease treatment: past, present, and future. J Neural Transm (Vienna) 127:785–791
Joyce RC, Tayo L, Chen B-Y, Po-Wei Tsai (2024) ) < i > in silico investigation of identified major metabolites from < i > Coffea Arabica leaves against Parkinson’s Disease Target proteins for neuroprotective Drug Development. Lett Drug Des Discovery 21:3030–3038
Kaserer T, Steinacher T, Kainhofer R, Erli F, Sturm S, Waltenberger B, Schuster D, Spetea M (2020) Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists. Sci Rep 10:13804
Article CAS PubMed PubMed Central Google Scholar
Wang HQ, Yan HJ, Wu HY, Li S Y. H (2017) Corydaline inhibits enterovirus 71 replication by regulating COX-2 expression. J Asian Nat Prod Res 19:1124–1133
Article CAS PubMed Google Scholar
Ji HY, Liu KH, Lee H, Im SR, Shim HJ, Son M, Lee HS (2011) Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules 16:6591–6602
Article CAS PubMed PubMed Central Google Scholar
Lee TH, Son M, Kim SY (2010) Effects of corydaline from Corydalis tuber on gastric motor function in an animal model. Biol Pharm Bull 33:958–962
Article CAS PubMed Google Scholar
Ma B, Shi S, Ren S, Qu C, Zhao Z, An H (2024) Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability. Eur J Pharmacol 962:176240
Article CAS PubMed Google Scholar
Zhou,Xu K S (2024) Corydaline alleviates Parkinson’s disease by regulating autophagy and GSK-3beta phosphorylation. Psychopharmacology 241:1027–1036
Feng JH, Chen K, Shen SY, Luo YF, Liu XH, Chen X, Gao W, Tong YR (2023) The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis Yanhusuo. Biomed Pharmacother 167:115511
Article CAS PubMed Google Scholar
Szczepanski,Wang AP L (2021) Emerging multifaceted roles of BAP1 complexes in biological processes. Cell Death Discov 7:20
Eletr,Wilkinson ZM K. D (2011) An emerging model for BAP1’s role in regulating cell cycle progression. Cell Biochem Biophys 60:3–11
Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, Sirohi K, Li X, Wei Y, Lee H, Zhuang L, Chen G, Xiao ZD, Hung MC, Chen J, Huang P, Li W, Gan B (2018) BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol 20:1181–1192
Article CAS PubMed PubMed Central Google Scholar
Xie Z, Lin H, Huang Y, Wang X, Lin H, Xu M, Wu J, Wu Y, Shen H, Zhang Q, Chen J, Deng Y, Xu Z, Chen Z, Lin Y, Han Y, Lin L, Yan L, Li Q, Lin X, Chi P (2024) BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer. Eur J Cancer 210:114278
Article CAS PubMed Google Scholar
Liu Y, Hu N, Ai B, Xia H, Li W (2024) MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis. BMC Cardiovasc Disord 24:286
Article CAS PubMed PubMed Central Google Scholar
Zhao J, Wan XN, Zhu JP, Liu QC, Gan L (2022) LncRNA NEAT1 promoted MPP+–induced ferroptosis via regulating miR–150–5p/BAP1 pathway in SK–N–SH cells. Acta Neurobiol Exp (Wars) 82:226–236
Pajares M, Rojo AI, Manda G, Bosca L, Cuadrado A (2020) Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications. Cells 9
Wang ZL, Yuan L, Li W, Li JY (2022) Ferroptosis in Parkinson’s disease: glia-neuron crosstalk. Trends Mol Med 28:258–269
Article CAS PubMed Google Scholar
Gupta S, Ahuja N, Kumar S, Arora R, Kumawat S, Kaushal V, Gupta P (2024) Rev-erbalpha regulate neurogenesis through suppression of Sox2 in neuronal cells to regenerate dopaminergic neurons and abates MPP(+) induced neuroinflammation. Free Radic Biol Med 223:144–159
Article CAS PubMed Google Scholar
Tao X, Zhang W, Chen C, Tao Y, Tao Y, Chen Z, Zhang G (2024) miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson’s disease models. Aging 16:8732–8746
Article CAS PubMed PubMed Central Google Scholar
Shen DF, Qi HP, Zhang WN, Sang WX (2023) Resveratrol promotes autophagy to improve neuronal injury in Parkinson’s disease by regulating SNHG1/miR-128-3p/SNCA axis. Brain Sci 13:1124
Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 23:101107
Article CAS PubMed PubMed Central Google Scholar
Yang W, Wang Y, Zhang C, Huang Y, Yu J, Shi L, Zhang P, Yin Y, Li R, Tao K (2022) Maresin1 protect against Ferroptosis-Induced Liver Injury through ROS Inhibition and Nrf2/HO-1/GPX4 activation. Front Pharmacol 13:865689
Article CAS PubMed PubMed Central Google Scholar
Zhang Y, Liu M, Zhang Y, Tian M, Chen P, Lan Y, Zhou B (2022) Urolithin A alleviates acute kidney injury induced by renal ischemia reperfusion through the p62-Keap1-Nrf2 signaling pathway. Phytother Res 36:984–995
Article CAS PubMed Google Scholar
Li S, Zhang ZL, Liu J, Wu X Z (2021) Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med 162:435–449
Comments (0)